SCHEMBL24263133

SCHEMBL24263133

Cn1nc2c(cc1=O)CC(NC(=O)c1ccc(F)cc1)CC2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
CTSB P07858 1/20 0.43
CTSS P25774 1/20 0.43
CTSK P43235 1/20 0.43
CTSC P53634 1/20 0.43
USP2 O75604 1/20 0.41
TSHR P16473 1/20 0.41
KMT2A Q03164 4/20 0.41
HPGD P15428 2/20 0.41
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
CCR3 P51677 2/20 0.40
MEN1 O00255 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MCHR1 Q99705 2/20 0.39
SLC6A12 P48065 1/20 0.39
TMEM97 Q5BJF2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24263083 0.90 NPC1 (0.46) NPC1RAB9AUSP2TSHRKMT2A
SCHEMBL24263202 0.89 CHRNB2 (0.47) KMT2AHDAC6MEN1
SCHEMBL24263096 0.89 ALDH1A1 (0.40) NPC1RAB9ATSHRKMT2AHPGD
SCHEMBL24263130 0.89 MEN1 (0.48) NPC1RAB9AKMT2AHPGDHDAC8
SCHEMBL24263099 0.89 HDAC8 (0.41) NPC1RAB9AKMT2AHPGDHDAC8
SCHEMBL24263210 0.89 MTNR1A (0.47) NPC1RAB9ACTSBCTSSCTSK
SCHEMBL24263225 0.85 SMN1; SMN2 (0.52) NPC1RAB9AKMT2AHPGDALDH1A1
SCHEMBL24263219 0.84 DRD4 (0.46) SLC6A12
SCHEMBL24263229 0.82 MEN1 (0.55) TSHRKMT2AHDAC8MEN1ALDH1A1
SCHEMBL24263232 0.81 MTNR1A (0.49) HPGDALDH1A1HTR2CMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022040508-A1 COMPOUNDS AND METHODS FOR TREATING AUTOIMMUNE DISORDERS BY TARGETING HLA-DQ2 IMMUNOMOLECULAR THERAPEUTICS, INC. (US) 2022-02-24 WO disclosed